ValiRx (VAL) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free VAL Stock Alerts GBX 3.45 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNew method discovered to halt active cancer cellsmsn.com - February 28 at 7:42 PMScientists discover 'two-punch' method to eliminate cancer cellsuk.news.yahoo.com - February 27 at 2:29 PMValiRx says requisition notice from shareholder group is invalidlse.co.uk - February 13 at 10:11 AMTRADING UPDATES: ValiRx receives shareholder request for board changelse.co.uk - February 9 at 8:27 PMEuropean Stocks Close Mostly Highermarkets.businessinsider.com - December 5 at 3:27 PMEuropean Markets Move Mostly Highermarkets.businessinsider.com - December 5 at 10:27 AMValiRx says ValiSeek inks deal to licence VAL401 drug with Ambroselse.co.uk - December 5 at 10:27 AMValiRx PLC EAJFmorningstar.com - November 15 at 9:30 AMValiRx signs deal to evaluate StingRay Bio drug candidateslse.co.uk - November 10 at 8:26 AMCORRECT (Oct 5): ICG Enterprise ups interim payout on better resultslse.co.uk - October 6 at 10:29 AMValiRx sees no reason for shares jump; notes TheoremRx mulls mergerlse.co.uk - October 6 at 10:29 AMVAL.L - ValiRx plcfinance.yahoo.com - September 11 at 5:14 PMValiRx interim loss widens as costs increase; hails Inaphaea progresslse.co.uk - August 24 at 9:18 AMValiRx Shares Rise on Higher Income Expectations From Inaphaea BioLabsmarketwatch.com - August 24 at 9:18 AMValiRx signs collaborative services agreement with Agilitylse.co.uk - August 14 at 4:27 AMValiRx Shares Rise After Collaborative Services Agreement With Agilitymarketwatch.com - August 14 at 4:27 AMValiRx Shares Rise After Subsidiary Secures Contractmarketwatch.com - July 19 at 8:08 AMTRADING UPDATES: All Things Considered raises funds to buy Sandbaglse.co.uk - June 28 at 6:45 PMValiRx shares drop after cancer drug research droppedlse.co.uk - June 16 at 9:10 AMValiRx Shares Fall After Cancer-Drug Development Abandonedmarketwatch.com - June 16 at 4:10 AMValiRx Changes IP Exclusivity Terms With TheoremRx to Exclude Greater Chinamarketwatch.com - June 8 at 10:44 AMValiRx expands cancer research agreement with University of Barcelonalse.co.uk - June 7 at 8:46 AMSelf Storage Gr Share Chatlse.co.uk - June 3 at 6:39 AMMilner Therapeutics Institute welcomes Cathy Tralau-Stewart as executive directormsn.com - May 4 at 4:31 PMGlobal Endometriosis Drugs Market Research Growth, Regions, Type and Application, Forecast Analysis to 2023-2030 By VMReportsmarketwatch.com - March 26 at 7:27 AMSuzy Dilly, ValiRx CEO reiterates her support for TheoremRx and hails 'brilliant science' Cytolytixlse.co.uk - November 10 at 4:30 AMValiRx teams with King's College London for cancer projectlse.co.uk - October 25 at 1:49 PMValiRx Shares Rise on Subsidiary's Intellectual Property License Agreementmarketwatch.com - October 25 at 1:49 PMGlobal Endometriosis Drugs Market to Reach $2.9 Billion by 2027 - Yahoo Financefinance.yahoo.com - October 18 at 10:11 AMValiRx Plc - Ada Lovelace Day 2022, in conversation with ValiRx's CEO - Marketscreener.commarketscreener.com - October 12 at 11:01 AMUK announces 40 billion-pound liquidity plan for power firms | Financial News - London South Eastlse.co.uk - September 8 at 8:20 AMUK plans to hold a "fiscal event" this month | Financial News - London South Eastlse.co.uk - September 8 at 8:20 AMValiRx Names Catherine Tralau-Stewart as Interim Chief Scientific Officer - MarketWatchmarketwatch.com - September 8 at 8:20 AMValiRx plc (EAJF.F)ca.finance.yahoo.com - September 5 at 7:05 PMEARNINGS UPDATES: Windward widens loss as operating expenses rise - Morningstarmorningstar.co.uk - September 1 at 12:06 AMEARNINGS UPDATES: Windward widens loss as operating expenses riselse.co.uk - August 31 at 5:49 PMIN BRIEF: ValiRx shares jump on breast cancer drug candidate progress | Financial News - London South Eastlse.co.uk - July 13 at 2:22 PMValiRx Shares Rise on Decision to Advance Breast-Cancer Treatment Program - MarketWatchmarketwatch.com - July 13 at 2:22 PMIN BRIEF:ValiRx gains GBP1.0 million from Turner Pope broker option - Morningstarmorningstar.co.uk - July 5 at 6:05 PMTRADING UPDATES: M&C Saatchi expects to deliver on annual profit - Morningstarmorningstar.co.uk - June 30 at 10:14 PMLONDON BRIEFING: UK house market starts to slow but car output rises - Morningstarmorningstar.co.uk - June 30 at 7:11 AMAIM WINNERS & LOSERS: Frasers invests in MySale; Kefi keeps license | Financial News - London South Eastlse.co.uk - June 30 at 7:11 AMAIM WINNERS & LOSERS: Frasers invests in MySale; Kefi keeps license - Morningstarmorningstar.co.uk - June 30 at 7:11 AMValiRx to Raise GBP1.5 Mln in Discounted Placing for Working Capital; Shares Fall - MarketWatchmarketwatch.com - June 30 at 7:11 AMValiRx Shares Fall on Potential Extension of Exclusivity Talks With TheoremRx - MarketWatchmarketwatch.com - June 18 at 6:21 PMAIM WINNERS & LOSERS: M&C Saatchi pulls Next Fifteen deal support - Morningstarmorningstar.co.uk - June 17 at 6:08 PMValiRx shares drop as cancer drug sub-licensing progress stalls - Morningstarmorningstar.co.uk - June 17 at 6:08 PMIN BRIEF: Literacy Capital sees uplifts across portfolio companies - Morningstarmorningstar.co.uk - June 7 at 6:28 PMIN BRIEF: ValiRx widens annual loss as R&D costs climb - Morningstarmorningstar.co.uk - June 7 at 6:28 PMValirx News Headlines. VAL Share News. Financial News Articles for Valirx Plc Ord 0.1P updated throughout the day. - London South Eastlse.co.uk - March 24 at 10:14 AM Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report VAL Media Mentions By Week VAL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VAL News Sentiment▼0.000.43▲Average Medical News Sentiment VAL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VAL Articles This Week▼00▲VAL Articles Average Week Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IXICO News Oxford Cannabinoid Technologies News Fusion Antibodies News Roquefort Therapeutics News Evgen Pharma News Physiomics News ReNeuron Group News ImmuPharma News BiVictriX Therapeutics News Synairgen News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:VAL) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
